Curve
PrivateLast Round
Series A
Feb 27, 2024
Total Funding Raised
$57.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Curve is a biotechnology company that develops modular, smart production systems for large-scale protein biomanufacturing across food, health, and cosmetic industries.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curve Comparables
Compare Curve with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| bbi-biotech GmbH | 80% | |
| Arsenale Bioyards | 78% | |
| Biosphere | 78% |
Curve Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 27, 2024 | ||||
| Seed | Jul 31, 2020 |
Key People
Founding team and executive leadership
Curve Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Series A, Seed |
| Advent Life Sciences | Series A, Seed |
| British Patient Capital | Series A |
| British Patient Capital | Series A |
| Pfizer Ventures | Series A |
| Columbus Venture Partners | Series A |
| Pfizer Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 709% MoM, from 185 to 1.5K.
- Nov 10, 2025
Developing modular, intelligent production systems for food and pharma.
Curve Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curve's valuation, stock price, and market status.
Is Curve a public or private company?
Curve is a private company.
What is the current stock price of Curve?
Curve is a private company, so its shares have no public market price. Caplight tracks Curve's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curve worth (valuation)?
Valuation information for Curve is not publicly available.
Can I buy Curve stock?
Curve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curve's last funding round?
Curve's most recent funding round was Series A on February 27, 2024.
Who are the main investors in Curve?
Key investors in Curve include Epidarex Capital, Advent Life Sciences, Pfizer Ventures, Pfizer Ventures.
Will Curve IPO soon?
No public IPO plans have been announced for Curve.
How can I track Curve secondary market activity?
Caplight tracks bids, offers, and trades in Curve's shares on secondary markets.